Pharmacokinetics of Baricitinib in Cerebrospinal Fluid and Plasma in a Patient with SPENCD

J Clin Immunol. 2024 Mar 8;44(3):78. doi: 10.1007/s10875-024-01680-2.
No abstract available

Publication types

  • Letter

MeSH terms

  • Autoimmune Diseases*
  • Azetidines* / therapeutic use
  • Humans
  • Immunologic Deficiency Syndromes*
  • Osteochondrodysplasias*
  • Purines*
  • Pyrazoles*
  • Sulfonamides

Substances

  • baricitinib
  • Azetidines
  • Sulfonamides
  • Purines
  • Pyrazoles

Supplementary concepts

  • Combined Immunodeficiency with Autoimmunity and Spondylometaphyseal Dysplasia